Genscript Biotech Co. (OTCMKTS:GNNSF) Sees Significant Increase in Short Interest

Genscript Biotech Co. (OTCMKTS:GNNSF) saw a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 3,266,600 shares, a growth of 832.2% from the March 15th total of 350,400 shares. Based on an average trading volume of 300 shares, the short-interest ratio is presently 10,888.7 days.

Genscript Biotech Price Performance

GNNSF opened at C$1.30 on Wednesday. The business has a fifty day simple moving average of C$1.55 and a 200-day simple moving average of C$1.42. Genscript Biotech has a fifty-two week low of C$1.05 and a fifty-two week high of C$1.90.

About Genscript Biotech

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.